SCHEMBL24046882

SCHEMBL24046882

O=c1cc(-c2ccc(O)c(Cl)n2)oc2c(Br)cc(Br)cc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A2 P19784 8/20 0.54
▸ CSNK2B P67870 8/20 0.54
▸ CSNK2A1 P68400 8/20 0.54
▸ CYSLTR2 Q9NS75 1/20 0.48
▸ CYSLTR1 Q9Y271 1/20 0.48
▸ TERT O14746 5/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ NQO1 P15559 1/20 0.39
▸ ESR1 P03372 1/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ CYP1A1 P04798 3/20 0.37
▸ CYP1A2 P05177 3/20 0.37
▸ CYP1B1 Q16678 3/20 0.37
▸ CSNK2A3 Q8NEV1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24046880 0.86 CSNK2A2 (0.55) CSNK2A2CSNK2BCSNK2A1CYSLTR2CYSLTR1
SCHEMBL24046876 0.85 CSNK2A2 (0.54) CSNK2A2CSNK2BCSNK2A1CYSLTR2CYSLTR1
SCHEMBL24046885 0.85 ALDH1A1 (0.44) CSNK2A2CSNK2BCSNK2A1CYSLTR2CYSLTR1
SCHEMBL24046873 0.82 CSNK2A2 (0.51) CSNK2A2CSNK2BCSNK2A1CYSLTR2CYSLTR1
SCHEMBL24046990 0.78 CSNK2A2 (0.50) CSNK2A2CSNK2BCSNK2A1CYSLTR2CYSLTR1
SCHEMBL24046755 0.76 CSNK2A2 (0.73) CSNK2A2CSNK2BCSNK2A1TERTMEN1
SCHEMBL24046883 0.73 CSNK2A2 (0.51) CSNK2A2CSNK2BCSNK2A1CYSLTR2CYSLTR1
SCHEMBL24046752 0.73 CSNK2A2 (0.78) CSNK2A2CSNK2BCSNK2A1TERTMEN1
SCHEMBL24046998 0.72 CSNK2A2 (0.72) CSNK2A2CSNK2BCSNK2A1TERTBRD4
SCHEMBL24046928 0.72 CSNK2A2 (0.65) CSNK2A2CSNK2BCSNK2A1TERTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021236578-A1 CHROMEN-4-ONE DERIVATIVES, SUCH AS E.G. FLAVONES, FOR USE AS CK2 INHIBITORS FOR THE TREATMENT OF NEUROINFLAMMATION SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2021-11-25 — — WO disclosed
Send feedback